The Pharmacovigilance Programme of India (Pv-PI) is meant to improve patient care and safety, contribute to assessment of benefit and risk associated with the use of medicines.
It is also meant to communicate safety information on use of medicines to various stakeholders to minimise the risk.
The programme was started nearly six years ago for monitoring adverse drug reactions in the country and safeguard public health.
It is intended to create a nation-wide system for patient safety reporting; identify and analyse new signals from reported cases; analyse the benefit-risk ratio of marketed medications; and generate evidence-based information on safety of medicines.
A CME programme will be held at AMC here on April 2 to train and educate health care professionals of Andhra Pradesh and Telangana on these aspects. The Regional Training Centre at Department of Clinical Pharmacology and Therapeutics, NIMS, under the National Coordination Centre of Pv-PI, is organising the programme, coordinator of the centre P. Usharani has informed.
